Condition: Hemophilia A With Inhibitor · Hemophilia B With Inhibitor · Sponsor: American Thrombosis and Hemostasis Network
Phase IV multi-center, US-centric, open-label, safety study enrolling participants with Hemophilia A or B with inhibitors, 12 years of age and older, who are either on long term prophylactic treatment (e.g., emicizumab) at risk of experiencing a breakthrough bleeding event (BE), or who are not on prophylactic treatment who may need to control a BE.
This description comes directly from the study's public registry record.
Carol Fedor, ND, RN, CCRC · (800)-360-2846 · cfedor@athn.org
Jessica Callis · 800-360-2846 · jcallis@athn.org
Always discuss trial participation with your own doctor first.
| Arizona Hemophilia and Thrombosis Center at Phoenix Children's Hospital | Phoenix, Arizona, United States | Completed |
| Arkansas Center for Bleeding Disorders | Little Rock, Arkansas, United States | Recruiting |
| Orthopaedic Institute for Children | Los Angeles, California, United States | Recruiting |
| University of California at Davis UC Davis Hemostasis and Thrombosis Center | Sacramento, California, United States | Recruiting |
| Children's National Hemophilia Center | Washington D.C., District of Columbia, United States | Completed |
| Arnold Palmer Hospital for Children - The Haley Center for Children's Cancer and Blood Disorders | Orlando, Florida, United States | Completed |
| Hemophilia of Georgia Center for Bleeding and Clotting Disorders of Emory, Adult Division | Atlanta, Georgia, United States | Recruiting |
| Willett Children's Hospital at Memorial University Medical Center | Savannah, Georgia, United States | Recruiting |
| Massachusetts General Hospital Comprehensive Hemophilia and Thrombosis Treatment Center | Boston, Massachusetts, United States | Recruiting |
| Children's Hospital of Michigan | Detroit, Michigan, United States | Recruiting |
| Henry Ford Health System | Detroit, Michigan, United States | Recruiting |
| MSU Center for Bleeding and Clotting Disorders | Lansing, Michigan, United States | Recruiting |
+ 9 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04647227